These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 6680096

  • 21. Differences in biological activity of the V3 envelope protein of two Japanese encephalitis virus strains.
    Takegami T, Miyamoto H, Nakamura H, Yasui K.
    Acta Virol; 1982 Sep; 26(5):321-7. PubMed ID: 6128901
    [Abstract] [Full Text] [Related]

  • 22. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP, Guirakhoo F, Nichols R, Yoksan S, Schrader R, Murphy C, Blum P, Woodward S, McCarthy K, Mathis D, Johnson C, Bedford P.
    J Infect Dis; 2003 Oct 15; 188(8):1213-30. PubMed ID: 14551893
    [Abstract] [Full Text] [Related]

  • 23. [Immunogenicity and stability of a Soviet inactivated cultured vaccine against Japanese encephalitis].
    Khanina MK, Bochkova NG, Grachev VP, El'bert LB, Vorob'eva MS, Borsuk EA, Pogodina VV.
    Vopr Virusol; 1990 Oct 15; 35(6):478-80. PubMed ID: 2082551
    [Abstract] [Full Text] [Related]

  • 24. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers.
    Van Gessel Y, Klade CS, Putnak R, Formica A, Krasaesub S, Spruth M, Cena B, Tungtaeng A, Gettayacamin M, Dewasthaly S.
    Vaccine; 2011 Aug 11; 29(35):5925-31. PubMed ID: 21723353
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Antigenic characterization of the live attenuated Japanese encephalitis vaccine virus SA14-14-2: a comparison with isolates of the virus covering a wide geographic area.
    Wills MR, Sil BK, Cao JX, Yu YX, Barrett AD.
    Vaccine; 1992 Aug 11; 10(12):861-72. PubMed ID: 1455912
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Antigenic analysis of Japanese encephalitis virus by using monoclonal antibodies.
    Kobayashi Y, Hasegawa H, Oyama T, Tamai T, Kusaba T.
    Infect Immun; 1984 Apr 11; 44(1):117-23. PubMed ID: 6200438
    [Abstract] [Full Text] [Related]

  • 31. Is a booster dose necessary in children after immunization with live attenuated Japanese encephalitis vaccine?
    Choi UY, Lee SY, Kim KH, Kim DS, Choi KM, Cha SH, Kang JH.
    J Trop Pediatr; 2013 Oct 11; 59(5):423-5. PubMed ID: 23764540
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines--report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies.
    Ferguson M, Johnes S, Li L, Heath A, Barrett A.
    Biologicals; 2008 Mar 11; 36(2):111-6. PubMed ID: 17892945
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Seroepidemiology study of Japanese encephalitis neutralizing antibodies in southern Taiwan: a comparative study between urban city and country townships.
    Tseng HF, Tan HF, Chang CK, Huang WL, Ho WC.
    Am J Infect Control; 2003 Nov 11; 31(7):435-40. PubMed ID: 14639442
    [Abstract] [Full Text] [Related]

  • 37. Protection against Japanese encephalitis by inactivated vaccines.
    Hoke CH, Nisalak A, Sangawhipa N, Jatanasen S, Laorakapongse T, Innis BL, Kotchasenee S, Gingrich JB, Latendresse J, Fukai K.
    N Engl J Med; 1988 Sep 08; 319(10):608-14. PubMed ID: 2842677
    [Abstract] [Full Text] [Related]

  • 38. [Immunological analysis of Japanese encephalitis virus using anti-Kamiyama monoclonal antibodies].
    Yamauchi T.
    Kansenshogaku Zasshi; 1989 Apr 08; 63(4):387-99. PubMed ID: 2506297
    [Abstract] [Full Text] [Related]

  • 39. Serological response to Japanese encephalitis vaccine in a group of school children in South Arcot district of Tamil Nadu.
    Mohan Rao CV, Risbud AR, Dandawate CN, Umarani UB, Ayachit VM, Rodrigues FM, Pavri KM.
    Indian J Med Res; 1993 Mar 08; 97():53-9. PubMed ID: 8505074
    [Abstract] [Full Text] [Related]

  • 40. Concomitant administration of live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) and measles, mumps, rubella (MMR) vaccine: randomized study in toddlers in Taiwan.
    Huang LM, Lin TY, Chiu CH, Chiu NC, Chen PY, Yeh SJ, Boaz M, Hutagalung Y, Bouckenooghe A, Feroldi E.
    Vaccine; 2014 Sep 15; 32(41):5363-9. PubMed ID: 24631095
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.